K. Ahmed, Y. Tabuchi, T. Kondo, Hyperthermia: an effective strategy to induce apoptosis in cancer cells, Apoptosis : an international journal on programmed cell death, 20 (2015) 1411-1419.
 M.W. Dewhirst, C.T. Lee, K.A. Ashcraft, The future of biology in driving the field of hyperthermia, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 32 (2016) 4-13.
 J.K. Kang, J.C. Kim, Y. Shin, S.M. Han, W.R. Won, J. Her, J.Y. Park, K.T. Oh, Principles and applications of nanomaterial-based hyperthermia in cancer therapy, Archives of pharmacal research, 43 (2020) 46-57.
 G. Lassche, J. Crezee, C.M.L. Van Herpen, Whole-body hyperthermia in combination with systemic therapy in advanced solid malignancies, Critical reviews in oncology/hematology, 139 (2019) 67-74.
 J. Beik, Z. Abed, F.S. Ghoreishi, S. Hosseini-Nami, S. Mehrzadi, A. Shakeri-Zadeh, S.K. Kamrava, Nanotechnology in hyperthermia cancer therapy: From fundamental principles to advanced applications, Journal of controlled release : official journal of the Controlled Release Society, 235 (2016) 205-221.
 N.R. Datta, S. Krishnan, D.E. Speiser, E. Neufeld, N. Kuster, S. Bodis, H. Hofmann, Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?, Cancer treatment reviews, 50 (2016) 217-227.
 H. Ghaffari, J. Beik, A. Talebi, S.R. Mahdavi, H. Abdollahi, New physical approaches to treat cancer stem cells: a review, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 20 (2018) 1502-1521.
 I. Pereira Gomes, J. Aparecida Duarte, A.L. Chaves Maia, D. Rubello, D.M. Townsend, A.L. Branco de Barros, E.A. Leite, Thermosensitive Nanosystems Associated with Hyperthermia for Cancer Treatment, Pharmaceuticals, 12 (2019).
 A. Sohail, Z. Ahmad, O.A. Beg, S. Arshad, L. Sherin, A review on hyperthermia via nanoparticle-mediated therapy, Bulletin du cancer, 104 (2017) 452-461.
 X. Wang, L. Cheng, Multifunctional two-dimensional nanocomposites for photothermal-based combined cancer therapy, Nanoscale, 11 (2019) 15685-15708.
 M. Agarwal, S. Pandita, C.R. Hunt, A. Gupta, X. Yue, S. Khan, R.K. Pandita, D. Pratt, J.W. Shay, J.S. Taylor, T.K. Pandita, Inhibition of telomerase activity enhances hyperthermia-mediated radiosensitization, Cancer research, 68 (2008) 3370-3378.
 J. Man, J.D. Shoemake, T. Ma, A.E. Rizzo, A.R. Godley, Q. Wu, A.M. Mohammadi, S. Bao, J.N. Rich, J.S. Yu, Hyperthermia Sensitizes Glioma Stem-like Cells to Radiation by Inhibiting AKT Signaling, Cancer research, 75 (2015) 1760-1769.
 H. Hatakeyama, S.Y. Wu, Y.A. Lyons, S. Pradeep, W. Wang, Q. Huang, K.A. Court, T. Liu, S. Nie, C. Rodriguez-Aguayo, F. Shen, Y. Huang, T. Hisamatsu, T. Mitamura, N. Jennings, J. Shim, P.L. Dorniak, L.S. Mangala, M. Petrillo, V.A. Petyuk, A.A. Schepmoes, A.K. Shukla, M. Torres-Lugo, J.S. Lee, K.D. Rodland, A. Fagotti, G. Lopez-Berestein, C. Li, A.K. Sood, Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers, Cell reports, 17 (2016) 1621-1631.
 L. Schaaf, M. Schwab, C. Ulmer, S. Heine, T.E. Murdter, J.O. Schmid, G. Sauer, W.E. Aulitzky, H. van der Kuip, Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest, Cancer research, 76 (2016) 2868-2875.
 J.K. Chen, W.L. Lin, Z. Chen, H.W. Liu, PARP-1-dependent recruitment of cold-inducible RNA-binding protein promotes double-strand break repair and genome stability, Proceedings of the National Academy of Sciences of the United States of America, 115 (2018) E1759-E1768.
 Y. Liao, L. Tong, L. Tang, S. Wu, The role of cold-inducible RNA binding protein in cell stress response, International journal of cancer, 141 (2017) 2164-2173.
 T.Y. Lin, Y. Chen, J.S. Jia, C. Zhou, M. Lian, Y.T. Wen, X.Y. Li, H.W. Chen, X.L. Lin, X.L. Zhang, S.J. Xiao, Y. Sun, D. Xiao, Loss of Cirbp expression is correlated with the malignant progression and poor prognosis in nasopharyngeal carcinoma, Cancer management and research, 11 (2019) 6959-6969.
 M. Lu, Q. Ge, G. Wang, Y. Luo, X. Wang, W. Jiang, X. Liu, C.L. Wu, Y. Xiao, X. Wang, CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1alpha, Cell death & disease, 9 (2018) 1046.
 D.A. Lujan, J.L. Ochoa, R.S. Hartley, Cold-inducible RNA binding protein in cancer and inflammation, Wiley interdisciplinary reviews. RNA, 9 (2018).
 P. Zhong, H. Huang, Recent progress in the research of cold-inducible RNA-binding protein, Future science OA, 3 (2017) FSO246.
 X. Zhu, C. Buhrer, S. Wellmann, Cold-inducible proteins CIRP and RBM3, a unique couple with activities far beyond the cold, Cellular and molecular life sciences : CMLS, 73 (2016) 3839-3859.
 M. Aziz, M. Brenner, P. Wang, Extracellular CIRP (eCIRP) and inflammation, Journal of leukocyte biology, 106 (2019) 133-146.
 M.M. Hoekstra, Y. Emmenegger, J. Hubbard, P. Franken, Cold-inducible RNA-binding protein (CIRBP) adjusts clock-gene expression and REM-sleep recovery following sleep deprivation, eLife, 8 (2019).
 Y. Liu, J. Xing, Y. Li, Q. Luo, Z. Su, X. Zhang, H. Zhang, Chronic hypoxia-induced Cirbp hypermethylation attenuates hypothermic cardioprotection via down-regulation of ubiquinone biosynthesis, Science translational medicine, 11 (2019).
 Y.J. Sun, S. Ma, B. Fan, Y. Wang, S.R. Wang, G.Y. Li, Therapeutic hypothermia protects photoreceptors through activating Cirbp pathway, Neurochemistry international, 126 (2019) 86-95.
 M. Rao, D. Ke, G. Cheng, S. Hu, Y. Wu, Y. Wang, F. Zhou, H. Liu, C. Zhu, W. Xia, The regulation of CIRBP by transforming growth factor beta during heat shock-induced testicular injury, Andrology, 7 (2019) 244-250.
 G. Cheng, D. Ke, M. Rao, S. Hu, Y. Wang, F. Zhou, H. Liu, C. Zhu, W. Xia, Effects of cold-inducible RNA-binding protein on the proliferation and apoptosis of spermatogenic cells in vitro following heat stress, Reproduction, fertility, and development, 31 (2019) 953-961.
 H. Nishiyama, S. Danno, Y. Kaneko, K. Itoh, H. Yokoi, M. Fukumoto, H. Okuno, J.L. Millan, T. Matsuda, O. Yoshida, J. Fujita, Decreased expression of cold-inducible RNA-binding protein (CIRP) in male germ cells at elevated temperature, The American journal of pathology, 152 (1998) 289-296.
 Y. Zeng, P. Kulkarni, T. Inoue, R.H. Getzenberg, Down-regulating cold shock protein genes impairs cancer cell survival and enhances chemosensitivity, Journal of cellular biochemistry, 107 (2009) 179-188.
 Y.P. Chen, A.T.C. Chan, Q.T. Le, P. Blanchard, Y. Sun, J. Ma, Nasopharyngeal carcinoma, Lancet, 394 (2019) 64-80.
 M.L.K. Chua, J.T.S. Wee, E.P. Hui, A.T.C. Chan, Nasopharyngeal carcinoma, Lancet, 387 (2016) 1012-1024.
 X.R. Tang, Y.Q. Li, S.B. Liang, W. Jiang, F. Liu, W.X. Ge, L.L. Tang, Y.P. Mao, Q.M. He, X.J. Yang, Y. Zhang, X. Wen, J. Zhang, Y.Q. Wang, P.P. Zhang, Y. Sun, J.P. Yun, J. Zeng, L. Li, L.Z. Liu, N. Liu, J. Ma, Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study, The Lancet. Oncology, 19 (2018) 382-393.
 Y. Hua, S. Ma, Z. Fu, Q. Hu, L. Wang, Y. Piao, Intracavity hyperthermia in nasopharyngeal cancer: a phase III clinical study, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 27 (2011) 180-186.
 M. Kang, W.Q. Liu, Y.T. Qin, Z.X. Wei, R.S. Wang, Long-term efficacy of microwave hyperthermia combined with chemoradiotherapy in treatment of nasopharyngeal carcinoma with cervical lymph node metastases, Asian Pacific journal of cancer prevention : APJCP, 14 (2013) 7395-7400.
 M.M. Paulides, G.C. Van Rhoon, Towards developing effective hyperthermia treatment for tumours in the nasopharyngeal region, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 27 (2011) 523-525; author reply 526.
 Q.L. Wen, L.J. He, P.R. Ren, C.Q. Chen, J.B. Wu, Comparing radiotherapy with or without intracavitary hyperthermia in the treatment of primary nasopharyngeal carcinoma: a retrospective analysis, Tumori, 100 (2014) 49-54.
 Y. Chen, X. Deng, W. Chen, P. Shi, M. Lian, H. Wang, K. Wang, D. Qian, D. Xiao, H. Long, Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2/AKT/beta-catenin pathway in glioma, Cell death & disease, 10 (2019) 448.
 X. Lin, J. Jia, T. Du, W. Li, X. Wang, J. Wei, X. Lin, H. Zeng, L. Yao, X. Chen, J. Zhuang, J. Weng, Y. Liu, J. Lin, Q. Wu, W. Wang, K. Yao, K. Xu, D. Xiao, Overexpression of miR-155 in the liver of transgenic mice alters the expression profiling of hepatic genes associated with lipid metabolism, PLoS ONE, 10 (2015) e0118417.
 X. Li, Z. Zhao, X. Zhang, S. Yang, X. Lin, X. Yang, X. Lin, J. Shi, S. Wang, W. Zhao, J. Li, F. Gao, M. Liu, N. Ma, W. Luo, K. Yao, Y. Sun, S. Xiao, D. Xiao, J. Jia, Klf4 reduces stemness phenotype, triggers mesenchymal-epithelial transition (MET)-like molecular changes, and prevents tumor progression in nasopharygeal carcinoma, Oncotarget, 8 (2017) 93924-93941.
 X. Lin, Y. Qin, J. Jia, T. Lin, X. Lin, L. Chen, H. Zeng, Y. Han, L. Wu, S. Huang, M. Wang, S. Huang, R. Xie, L. Liang, Y. Liu, R. Liu, T. Zhang, J. Li, S. Wang, P. Sun, W. Huang, K. Yao, K. Xu, T. Du, D. Xiao, MiR-155 Enhances Insulin Sensitivity by Coordinated Regulation of Multiple Genes in Mice, PLoS genetics, 12 (2016) e1006308.
 J.W. Shi, T.T. Zhang, W. Liu, J. Yang, X.L. Lin, J.S. Jia, H.F. Shen, S.C. Wang, J. Li, W.T. Zhao, W.W. Gu, Y. Sun, D. Xiao, Direct conversion of pig fibroblasts to chondrocyte-like cells by c-Myc, Cell death discovery, 5 (2019) 55.
 Y. Sun, D. Xiao, H.A. Li, J.F. Jiang, Q. Li, R.S. Zhang, X.G. Chen, Phenotypic changes of human cells in human-rat liver during partial hepatectomy-induced regeneration, World journal of gastroenterology, 15 (2009) 3611-3620.
 S.C. Wang, X.L. Lin, H.Y. Wang, Y.J. Qin, L. Chen, J. Li, J.S. Jia, H.F. Shen, S. Yang, R.Y. Xie, F. Wei, F. Gao, X.X. Rong, J. Yang, W.T. Zhao, T.T. Zhang, J.W. Shi, K.T. Yao, W.R. Luo, Y. Sun, D. Xiao, Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway, Oncotarget, 6 (2015) 36713-36730.
 R. Xie, X. Lin, T. Du, K. Xu, H. Shen, F. Wei, W. Hao, T. Lin, X. Lin, Y. Qin, H. Wang, L. Chen, S. Yang, J. Yang, X. Rong, K. Yao, D. Xiao, J. Jia, Y. Sun, Targeted Disruption of miR-17-92 Impairs Mouse Spermatogenesis by Activating mTOR Signaling Pathway, Medicine, 95 (2016) e2713.
 W.T. Zhao, X.L. Lin, Y. Liu, L.X. Han, J. Li, T.Y. Lin, J.W. Shi, S.C. Wang, M. Lian, H.W. Chen, Y. Sun, K. Xu, J.S. Jia, R.C. Luo, D. Xiao, miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2, Laboratory investigation; a journal of technical methods and pathology, 99 (2019) 1484-1500.
 J. Li, S. Yang, W. Yan, J. Yang, Y.J. Qin, X.L. Lin, R.Y. Xie, S.C. Wang, W. Jin, F. Gao, J.W. Shi, W.T. Zhao, J.S. Jia, H.F. Shen, J.R. Ke, B. Liu, Y.Q. Zhao, W.H. Huang, K.T. Yao, D.J. Li, D. Xiao, MicroRNA-19 triggers epithelial-mesenchymal transition of lung cancer cells accompanied by growth inhibition, Laboratory investigation; a journal of technical methods and pathology, 95 (2015) 1056-1070.
 X. Lin, L. Chen, H. Li, Y. Liu, Y. Guan, X. Li, Z. Jia, X. Lin, J. Jia, Y. Sun, D. Xiao, miR-155 accelerates proliferation of mouse hepatocytes during liver regeneration by directly targeting SOCS1, American journal of physiology. Gastrointestinal and liver physiology, 315 (2018) G443-g453.
 S.C. Wang, X.L. Lin, J. Li, T.T. Zhang, H.Y. Wang, J.W. Shi, S. Yang, W.T. Zhao, R.Y. Xie, F. Wei, Y.J. Qin, L. Chen, J. Yang, K.T. Yao, D. Xiao, MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA, PLoS ONE, 9 (2014) e101330.
 X.X. Rong, F. Wei, X.L. Lin, Y.J. Qin, L. Chen, H.Y. Wang, H.F. Shen, L.T. Jia, R.Y. Xie, T.Y. Lin, W.C. Hao, J. Yang, S. Yang, Y.S. Cheng, W.H. Huang, A.M. Li, Y. Sun, R.C. Luo, D. Xiao, Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognition, Oncoimmunology, 5 (2016) e1086060.
 F. Wei, X.X. Rong, R.Y. Xie, L.T. Jia, H.Y. Wang, Y.J. Qin, L. Chen, H.F. Shen, X.L. Lin, J. Yang, S. Yang, W.C. Hao, Y. Chen, S.J. Xiao, H.R. Zhou, T.Y. Lin, Y.S. Chen, Y. Sun, K.T. Yao, D. Xiao, Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition, Oncotarget, 6 (2015) 35023-35039.
 J.W. Shi, W. Liu, T.T. Zhang, S.C. Wang, X.L. Lin, J. Li, J.S. Jia, H.F. Sheng, Z.F. Yao, W.T. Zhao, Z.L. Zhao, R.Y. Xie, S. Yang, F. Gao, Q.R. Fan, M.Y. Zhang, M. Yue, J. Yuan, W.W. Gu, K.T. Yao, D. Xiao, The enforced expression of c-Myc in pig fibroblasts triggers mesenchymal-epithelial transition (MET) via F-actin reorganization and RhoA/Rock pathway inactivation, Cell cycle (Georgetown, Tex.), 12 (2013) 1119-1127.
 P. Chomczynski, N. Sacchi, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Analytical biochemistry, 162 (1987) 156-159.
 M. Hou, C. Yan, Z. Chen, Q. Zhao, M. Yuan, Y. Xu, B. Zhao, Multifunctional NIR-responsive poly(vinylpyrrolidone)-Cu-Sb-S nanotheranostic agent for photoacoustic imaging and photothermal/photodynamic therapy, Acta biomaterialia, 74 (2018) 334-343.
 G. Dontu, W.M. Abdallah, J.M. Foley, K.W. Jackson, M.F. Clarke, M.J. Kawamura, M.S. Wicha, In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells, Genes & development, 17 (2003) 1253-1270.
 Q.L. Kong, L.J. Hu, J.Y. Cao, Y.J. Huang, L.H. Xu, Y. Liang, D. Xiong, S. Guan, B.H. Guo, H.Q. Mai, Q.Y. Chen, X. Zhang, M.Z. Li, J.Y. Shao, C.N. Qian, Y.F. Xia, L.B. Song, Y.X. Zeng, M.S. Zeng, Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma, PLoS pathogens, 6 (2010) e1000940.
 J. Wang, L.P. Guo, L.Z. Chen, Y.X. Zeng, S.H. Lu, Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line, Cancer research, 67 (2007) 3716-3724.
 P.K. Lo, D. Kanojia, X. Liu, U.P. Singh, F.G. Berger, Q. Wang, H. Chen, CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFbeta signaling, Oncogene, 31 (2012) 2614-2626.
 H.L. Huang, H.Y. Weng, L.Q. Wang, C.H. Yu, Q.J. Huang, P.P. Zhao, J.Z. Wen, H. Zhou, L.H. Qu, Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis, Molecular cancer therapeutics, 11 (2012) 1155-1165.
 S. Li, D. Shi, L. Zhang, F. Yang, G. Cheng, Oridonin enhances the radiosensitivity of lung cancer cells by upregulating Bax and downregulating Bcl-2, Experimental and therapeutic medicine, 16 (2018) 4859-4864.
 Y. Lu, Y. Sun, J. Zhu, L. Yu, X. Jiang, J. Zhang, X. Dong, B. Ma, Q. Zhang, Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-gamma and inhibiting Nrf2 pathway, Cell death & disease, 9 (2018) 15.
 H. Luo, C.T. Vong, H. Chen, Y. Gao, P. Lyu, L. Qiu, M. Zhao, Q. Liu, Z. Cheng, J. Zou, P. Yao, C. Gao, J. Wei, C.O.L. Ung, S. Wang, Z. Zhong, Y. Wang, Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine, Chinese medicine, 14 (2019) 48.
 M. Ming, F.Y. Sun, W.T. Zhang, J.K. Liu, Therapeutic effect of oridonin on mice with prostate cancer, Asian Pacific journal of tropical medicine, 9 (2016) 184-187.
 B.A. Owona, H.J. Schluesener, Molecular Insight in the Multifunctional Effects of Oridonin, Drugs in R&D, 15 (2015) 233-244.
 X. Shen, L. Zhao, P. Chen, Y. Gong, D. Liu, X. Zhang, L. Dai, Q. Sun, J. Lou, Z. Jin, B. Zhang, D. Niu, C. Chen, X. Qi, D. Jia, A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3, The Journal of biological chemistry, 294 (2019) 17471-17486.
 M. Song, X. Liu, K. Liu, R. Zhao, H. Huang, Y. Shi, M. Zhang, S. Zhou, H. Xie, H. Chen, Y. Li, Y. Zheng, Q. Wu, F. Liu, E. Li, A.M. Bode, Z. Dong, M.H. Lee, Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo, Molecular cancer therapeutics, 17 (2018) 1540-1553.
 M. Vasaturo, R. Cotugno, L. Fiengo, C. Vinegoni, F. Dal Piaz, N. De Tommasi, The anti-tumor diterpene oridonin is a direct inhibitor of Nucleolin in cancer cells, Scientific reports, 8 (2018) 16735.
 H. Weng, H. Huang, B. Dong, P. Zhao, H. Zhou, L. Qu, Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S, Cancer research, 74 (2014) 4409-4419.
 S. Xu, H. Yao, M. Hu, D. Li, Z. Zhu, W. Xie, H. Yao, L. Wu, Z.S. Chen, J. Xu, 6,7-Seco-ent-Kauranoids Derived from Oridonin as Potential Anticancer Agents, J Nat Prod, 80 (2017) 2391-2398.
 Y. Xu, J. Liu, Y. Wu, Q. Guo, H. Sun, G. Chen, Natural products against hematological malignancies and identification of their targets, Science China. Life sciences, 58 (2015) 1191-1201.
 Z. Yao, F. Xie, M. Li, Z. Liang, W. Xu, J. Yang, C. Liu, H. Li, H. Zhou, L.H. Qu, Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells, Cell death & disease, 8 (2017) e2633.
 Y. Zhao, H. Xia, Oridonin elevates sensitivity of ovarian carcinoma cells to cisplatin via suppressing cisplatin-mediated autophagy, Life sciences, 233 (2019) 116709.
 T. Zhen, C.F. Wu, P. Liu, H.Y. Wu, G.B. Zhou, Y. Lu, J.X. Liu, Y. Liang, K.K. Li, Y.Y. Wang, Y.Y. Xie, M.M. He, H.M. Cao, W.N. Zhang, L.M. Chen, K. Petrie, S.J. Chen, Z. Chen, Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein, Science translational medicine, 4 (2012) 127ra138.
 E. Bessede, C. Staedel, L.A. Acuna Amador, P.H. Nguyen, L. Chambonnier, M. Hatakeyama, G. Belleannee, F. Megraud, C. Varon, Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes, Oncogene, 33 (2014) 4123-4131.
 S.Y. Lee, E.K. Jeong, M.K. Ju, H.M. Jeon, M.Y. Kim, C.H. Kim, H.G. Park, S.I. Han, H.S. Kang, Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation, Molecular cancer, 16 (2017) 10.
 S.A. Mani, W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, L.L. Campbell, K. Polyak, C. Brisken, J. Yang, R.A. Weinberg, The epithelial-mesenchymal transition generates cells with properties of stem cells, Cell, 133 (2008) 704-715.
 G.S. Markopoulos, E. Roupakia, K.B. Marcu, E. Kolettas, Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation, Cells, 8 (2019).
 M. Najafi, B. Farhood, K. Mortezaee, Cancer stem cells (CSCs) in cancer progression and therapy, Journal of cellular physiology, 234 (2019) 8381-8395.
 X. Jiao, X. Qian, L. Wu, B. Li, Y. Wang, X. Kong, L. Xiong, microRNA: The Impact on Cancer Stemness and Therapeutic Resistance, Cells, 9 (2019).
 M.R. Atashzar, R. Baharlou, J. Karami, H. Abdollahi, R. Rezaei, F. Pourramezan, S.H. Zoljalali Moghaddam, Cancer stem cells: A review from origin to therapeutic implications, Journal of cellular physiology, 235 (2020) 790-803.
 R.L. Bighetti-Trevisan, L.O. Sousa, R.M. Castilho, L.O. Almeida, Cancer Stem Cells: Powerful Targets to Improve Current Anticancer Therapeutics, Stem cells international, 2019 (2019) 9618065.
 F.Y. Du, Q.F. Zhou, W.J. Sun, G.L. Chen, Targeting cancer stem cells in drug discovery: Current state and future perspectives, World journal of stem cells, 11 (2019) 398-420.
 M.E. Lleonart, A new generation of proto-oncogenes: cold-inducible RNA binding proteins, Biochimica et biophysica acta, 1805 (2010) 43-52.
 J.J. Wong, A.Y. Au, D. Gao, N. Pinello, C.T. Kwok, A. Thoeng, K.A. Lau, J.E. Gordon, U. Schmitz, Y. Feng, T.V. Nguyen, R. Middleton, C.G. Bailey, J. Holst, J.E. Rasko, W. Ritchie, RBM3 regulates temperature sensitive miR-142-5p and miR-143 (thermomiRs), which target immune genes and control fever, Nucleic acids research, 44 (2016) 2888-2897.
 G. Tong, N.N.A. von Garlen, S.J. Wowro, P.D. Lam, J. Krech, F. Berger, K.R.L. Schmitt, Post-TTM Rebound Pyrexia after Ischemia-Reperfusion Injury Results in Sterile Inflammation and Apoptosis in Cardiomyocytes, Mediators of inflammation, 2019 (2019) 6431957.
 S. Biswas, MicroRNAs as Therapeutic Agents: The Future of the Battle Against Cancer, Current topics in medicinal chemistry, 18 (2018) 2544-2554.
 C.M. Croce, Causes and consequences of microRNA dysregulation in cancer, Nature reviews. Genetics, 10 (2009) 704-714.
 R. Garzon, G.A. Calin, C.M. Croce, MicroRNAs in Cancer, Annual review of medicine, 60 (2009) 167-179.
 A. Nadeem, M.R. Ashraf, M. Javed, T. Hussain, M.S. Tariq, M.E. Babar, Review - MicroRNAs: A new paradigm towards mechanistic insight of diseases, Pakistan journal of pharmaceutical sciences, 31 (2018) 2017-2026.
 K. Saliminejad, H.R. Khorram Khorshid, S. Soleymani Fard, S.H. Ghaffari, An overview of microRNAs: Biology, functions, therapeutics, and analysis methods, Journal of cellular physiology, 234 (2019) 5451-5465.
 H. Ling, M. Fabbri, G.A. Calin, MicroRNAs and other non-coding RNAs as targets for anticancer drug development, Nature reviews. Drug discovery, 12 (2013) 847-865.
 R. Rupaimoole, F.J. Slack, MicroRNA therapeutics: towards a new era for the management of cancer and other diseases, Nature reviews. Drug discovery, 16 (2017) 203-222.
 K.D. Barnes, G. Shafirstein, J.S. Webber, N.A. Koonce, Z. Harris, R.J. Griffin, Hyperthermia-enhanced indocyanine green delivery for laser-induced thermal ablation of carcinomas, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 29 (2013) 474-479.
 G. Sheng, Y. Chen, L. Han, Y. Huang, X. Liu, L. Li, Z. Mao, Encapsulation of indocyanine green into cell membrane capsules for photothermal cancer therapy, Acta biomaterialia, 43 (2016) 251-261.
 C. Shirata, J. Kaneko, Y. Inagaki, T. Kokudo, M. Sato, S. Kiritani, N. Akamatsu, J. Arita, Y. Sakamoto, K. Hasegawa, N. Kokudo, Near-infrared photothermal/photodynamic therapy with indocyanine green induces apoptosis of hepatocellular carcinoma cells through oxidative stress, Scientific reports, 7 (2017) 13958.
 G. Wan, B. Chen, L. Li, D. Wang, S. Shi, T. Zhang, Y. Wang, L. Zhang, Y. Wang, Nanoscaled red blood cells facilitate breast cancer treatment by combining photothermal/photodynamic therapy and chemotherapy, Biomaterials, 155 (2018) 25-40.
 N. Zhang, M. Li, X. Sun, H. Jia, W. Liu, NIR-responsive cancer cytomembrane-cloaked carrier-free nanosystems for highly efficient and self-targeted tumor drug delivery, Biomaterials, 159 (2018) 25-36.
 Y.Y. Zhao, Q. Wu, Z.B. Wu, J.J. Zhang, L.C. Zhu, Y. Yang, S.L. Ma, S.R. Zhang, Microwave hyperthermia promotes caspase3-dependent apoptosis and induces G2/M checkpoint arrest via the ATM pathway in nonsmall cell lung cancer cells, Int J Oncol, 53 (2018) 539-550.
 H.N. Lee, S.M. Ahn, H.H. Jang, Cold-inducible RNA-binding protein, CIRP, inhibits DNA damage-induced apoptosis by regulating p53, Biochemical and biophysical research communications, 464 (2015) 916-921.
 Z. Li, E.K. Fan, J. Liu, M.J. Scott, Y. Li, S. Li, W. Xie, T.R. Billiar, M.A. Wilson, Y. Jiang, P. Wang, J. Fan, Cold-inducible RNA-binding protein through TLR4 signaling induces mitochondrial DNA fragmentation and regulates macrophage cell death after trauma, Cell death & disease, 8 (2017) e2775.
 L. Gong, Q. Zhang, X. Pan, S. Chen, L. Yang, B. Liu, W. Yang, L. Yu, Z.X. Xiao, X.H. Feng, H. Wang, Z.M. Yuan, J. Peng, W.Q. Tan, J. Chen, p53 Protects Cells from Death at the Heatstroke Threshold Temperature, Cell reports, 29 (2019) 3693-3707 e3695.
 J. Guan, E. Stavridi, D.B. Leeper, G. Iliakis, Effects of hyperthermia on p53 protein expression and activity, Journal of cellular physiology, 190 (2002) 365-374.
 C.R. Hunt, R.K. Pandita, A. Laszlo, R. Higashikubo, M. Agarwal, T. Kitamura, A. Gupta, N. Rief, N. Horikoshi, R. Baskaran, J.H. Lee, M. Lobrich, T.T. Paull, J.L. Roti Roti, T.K. Pandita, Hyperthermia activates a subset of ataxia-telangiectasia mutated effectors independent of DNA strand breaks and heat shock protein 70 status, Cancer research, 67 (2007) 3010-3017.
 J. Smith, L.M. Tho, N. Xu, D.A. Gillespie, The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer, Advances in cancer research, 108 (2010) 73-112.
 M. Tomita, Involvement of DNA-PK and ATM in radiation- and heat-induced DNA damage recognition and apoptotic cell death, Journal of radiation research, 51 (2010) 493-501.
 M. Tuul, H. Kitao, M. Iimori, K. Matsuoka, S. Kiyonari, H. Saeki, E. Oki, M. Morita, Y. Maehara, Rad9, Rad17, TopBP1 and claspin play essential roles in heat-induced activation of ATR kinase and heat tolerance, PloS one, 8 (2013) e55361.
 X. Liu, Y. Zhang, Y. Wang, W. Zhu, G. Li, X. Ma, Y. Zhang, S. Chen, S. Tiwari, K. Shi, S. Zhang, H.M. Fan, Y.X. Zhao, X.J. Liang, Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy, Theranostics, 10 (2020) 3793-3815.
 K.A. Court, H. Hatakeyama, S.Y. Wu, M.S. Lingegowda, C. Rodriguez-Aguayo, G. Lopez-Berestein, L. Ju-Seog, C. Rinaldi, E.J. Juan, A.K. Sood, M. Torres-Lugo, HSP70 Inhibition Synergistically Enhances the Effects of Magnetic Fluid Hyperthermia in Ovarian Cancer, Molecular cancer therapeutics, 16 (2017) 966-976.
 J. Shao, B. Han, P. Cao, B. Zhang, M. Liu, D. Li, N. Zhou, Q. Hao, X. Duan, Y. Chang, A. Nakai, Y. Fan, K. Tan, HSF1 phosphorylation by cyclosporin A confers hyperthermia sensitivity through suppression of HSP expression, Biochimica et biophysica acta. Gene regulatory mechanisms, 1862 (2019) 846-857.
 L.E.M. Vriend, N. van den Tempel, A.L. Oei, M. L'Acosta, F.J. Pieterson, N.A.P. Franken, R. Kanaar, P.M. Krawczyk, Boosting the effects of hyperthermia-based anticancer treatments by HSP90 inhibition, Oncotarget, 8 (2017) 97490-97503.
 C. Mu, X. Wu, X. Zhou, J. Wolfram, J. Shen, D. Zhang, J. Mai, X. Xia, A.M. Holder, M. Ferrari, X. Liu, H. Shen, Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer, Clinical cancer research : an official journal of the American Association for Cancer Research, 24 (2018) 4900-4912.
 L. Wu, H.L. Sun, Y. Gao, K.L. Hui, M.M. Xu, H. Zhong, M.L. Duan, Therapeutic Hypothermia Enhances Cold-Inducible RNA-Binding Protein Expression and Inhibits Mitochondrial Apoptosis in a Rat Model of Cardiac Arrest, Molecular neurobiology, 54 (2017) 2697-2705.
 K. Saito, N. Fukuda, T. Matsumoto, Y. Iribe, A. Tsunemi, T. Kazama, C. Yoshida-Noro, N. Hayashi, Moderate low temperature preserves the stemness of neural stem cells and suppresses apoptosis of the cells via activation of the cold-inducible RNA binding protein, Brain research, 1358 (2010) 20-29.
 Q. Zhang, Y.Z. Wang, W. Zhang, X. Chen, J. Wang, J. Chen, W. Luo, Involvement of Cold Inducible RNA-Binding Protein in Severe Hypoxia-Induced Growth Arrest of Neural Stem Cells In Vitro, Molecular neurobiology, 54 (2017) 2143-2153.
 H.L. Janssen, H.W. Reesink, E.J. Lawitz, S. Zeuzem, M. Rodriguez-Torres, K. Patel, A.J. van der Meer, A.K. Patick, A. Chen, Y. Zhou, R. Persson, B.D. King, S. Kauppinen, A.A. Levin, M.R. Hodges, Treatment of HCV infection by targeting microRNA, The New England journal of medicine, 368 (2013) 1685-1694.
 W.B. Coley, The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus), Proceedings of the Royal Society of Medicine, 3 (1910) 1-48.
 L.R. Zacharski, V.P. Sukhatme, Coley's toxin revisited: immunotherapy or plasminogen activator therapy of cancer?, Journal of thrombosis and haemostasis : JTH, 3 (2005) 424-427.
 T. Lim, I. Lee, J. Kim, W.K. Kang, Synergistic Effect of Simvastatin Plus Radiation in Gastric Cancer and Colorectal Cancer: Implications of BIRC5 and Connective Tissue Growth Factor, International journal of radiation oncology, biology, physics, 93 (2015) 316-325.
 F.K. Storm, L.R. Kaiser, J.E. Goodnight, W.H. Harrison, R.S. Elliott, A.S. Gomes, D.L. Morton, Thermochemotherapy for melanoma metastases in liver, Cancer, 49 (1982) 1243-1248.
 N.R. Datta, A.K. Bose, H.K. Kapoor, S. Gupta, Head and neck cancers: results of thermoradiotherapy versus radiotherapy, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 6 (1990) 479-486.
 R. Valdagni, M. Amichetti, Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients, International journal of radiation oncology, biology, physics, 28 (1994) 163-169.
 J. Overgaard, D. Gonzalez Gonzalez, M.C. Hulshof, G. Arcangeli, O. Dahl, O. Mella, S.M. Bentzen, Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology, Lancet, 345 (1995) 540-543.
 C.C. Vernon, J.W. Hand, S.B. Field, D. Machin, J.B. Whaley, J. van der Zee, W.L. van Putten, G.C. van Rhoon, J.D. van Dijk, D. González González, F.F. Liu, P. Goodman, M. Sherar, Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group, International journal of radiation oncology, biology, physics, 35 (1996) 731-744.
 E.L. Jones, J.R. Oleson, L.R. Prosnitz, T.V. Samulski, Z. Vujaskovic, D. Yu, L.L. Sanders, M.W. Dewhirst, Randomized trial of hyperthermia and radiation for superficial tumors, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 (2005) 3079-3085.
 M. Linthorst, A.N. van Geel, M. Baaijens, A. Ameziane, W. Ghidey, G.C. van Rhoon, J. van der Zee, Re-irradiation and hyperthermia after surgery for recurrent breast cancer, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 109 (2013) 188-193.
 J. Van der Zee, G.C. Van Rhoon, M.P. Broekmeyer-Reurink, A.E. Kuijs, A.P. Van Den Berg, D. Treurniet-Donker, W.L. Van Putten, H.S. Reinhold, Clinical experience with local hyperthermia in Rotterdam, Advances in experimental medicine and biology, 267 (1990) 383-386.
 Y. Harima, K. Nagata, K. Harima, V.V. Ostapenko, Y. Tanaka, S. Sawada, A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 17 (2001) 97-105.
 A. Zolciak-Siwinska, N. Piotrkowicz, J. Jonska-Gmyrek, M. Nicke-Psikuta, W. Michalski, M. Kawczyńska, M. Bijok, K. Bujko, HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy--a phase III study, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 109 (2013) 194-199.
 P.K. Sneed, P.R. Stauffer, M.W. McDermott, C.J. Diederich, K.R. Lamborn, M.D. Prados, S. Chang, K.A. Weaver, L. Spry, M.K. Malec, S.A. Lamb, B. Voss, R.L. Davis, W.M. Wara, D.A. Larson, T.L. Phillips, P.H. Gutin, Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme, International journal of radiation oncology, biology, physics, 40 (1998) 287-295.
 M.H. Falk, R.D. Issels, Hyperthermia in oncology, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 17 (2001) 1-18.
 M.Y. Klimanov, L.A. Syvak, V.E. Orel, G.V. Lavryk, T.Y. Tarasenko, V.B. Orel, A.Y. Rykhalskyi, V.V. Stegnii, A.O. Nesterenko, Efficacy of Combined Regional Inductive Moderate Hyperthermia and Chemotherapy in Patients With Multiple Liver Metastases From Breast Cancer, Technology in cancer research & treatment, 17 (2018) 1533033818806003.
 H. He, H. Jiang, Y. Chen, J. Ye, A. Wang, C. Wang, Q. Liu, G. Liang, X. Deng, W. Jiang, R. Zhou, Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity, Nature communications, 9 (2018) 2550.
 K. Dzobo, D.A. Senthebane, C. Ganz, N.E. Thomford, A. Wonkam, C. Dandara, Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review, Cells, 9 (2020).
 T. Huang, X. Song, D. Xu, D. Tiek, A. Goenka, B. Wu, N. Sastry, B. Hu, S.Y. Cheng, Stem cell programs in cancer initiation, progression, and therapy resistance, Theranostics, 10 (2020) 8721-8743.
 H. Li, Z. Feng, M.L. He, Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells, Theranostics, 10 (2020) 7053-7069.